The amount funded to support the study payable in annual installment.

No definition available.

Name:	ird_AmountFundedToSupportStudyPayableInAnnualInstallment
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount funded to support the study payable in initial installment at the time of the agreement.

+ References

No definition available.

+ Details

Name:	ird_AmountFundedToSupportStudyPayableInInitialInstallment
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Consultation services receivable period from member of the board, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	ird_ConsultationServicesReceivablePeriod
Namespace Prefix:	ird_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate total of expenses of consulting with an entity.

+ References

No definition available.

+ Details

Name:	ird_ConsultingExpense
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of installments to paid monthly for the loan repayment.

+ References

No definition available.

+ Details

Name:	ird_DebtInstrumentNumberOfInstallments
Namespace Prefix:	ird_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The final installment amount funded to support the study payable upon upon receipt of semi-annual reports.

+ References

No definition available.

+ Details

Name:	ird_FinalInstallmentPayableUponReceiptOfSemiAnnualReportsOfStudy
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The maximum amount funded to support the study.

+ References

No definition available.

+ Details

Name:	ird_MaximumAmountFundedToSupportStudy
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Potential additional installment payment related to the Foundation Fighting Blindness Retinal Degeneration Fund agreement.

+ References

No definition available.

+ Details

Name:	ird_PaymentOfAdditionalInstallmentToSupportStudyUnderAgreement
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate amount paid by the entity related to 2022 Binding Letter Agreement upon its termination.

+ References

No definition available.

+ Details

Name:	ird_PaymentOfFinalInstallmentUponTerminationOfAgreement
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payment of initial installment amount related to the Foundation Fighting Blindness agreement.

+ References

No definition available.

+ Details

Name:	ird_PaymentOfInitialInstallmentToSupportStudyUnderAgreement
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The payable amount related to funded to support the study due under the 2022 Binding Letter Agreement.

+ References

No definition available.

+ Details

Name:	ird_PaymentsDueRelatedToAmountFundedToSupportStudy
Namespace Prefix:	ird_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Period of agreement termination after study completion in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	ird_PeriodOfAgreementTerminationAfterStudyCompletion
Namespace Prefix:	ird_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	ird_PreMergerFinancingAndWaiverAgreementsAbstract
Namespace Prefix:	ird_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of equal installments for share-based compensation awards to vest.

+ References

No definition available.

+ Details

Name:	ird_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEqualInstallmentsForAwardsToVest
Namespace Prefix:	ird_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of liabilities classified as other.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 64
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481620/480-10-55-64

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(12)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(12)(b)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(12)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(17))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

+ Details

Name:	us-gaap_OtherLiabilities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of transactions with related party during the financial reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

Name:	us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=ird_BoardMemberMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=ird_March2025PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=ird_ChairmanOfTheBoardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=ird_EquityIncentivePlan2020Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ird_FoundationFightingBlindnessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=ird_BindingLetterAgreement2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=ird_LetterAgreement2025Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ird_CamGallagherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ird_SeanAinsworthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions, Consulting, Letter Agreements and Strategic Partnership (Details)								6 Months Ended	12 Months Ended
	Aug. 25, 2025 USD ($) shares	May 27, 2025 USD ($) Installment	Mar. 21, 2025 USD ($)	Oct. 22, 2024 shares	May 11, 2024 Installment	Apr. 11, 2024 shares	Aug. 25, 2022 USD ($) Installment	Jun. 30, 2025 USD ($)	Dec. 31, 2025 USD ($) shares	Dec. 31, 2024 USD ($) shares
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares									22,229,102
Proceeds from issuance of common stock									$ 5,805,000	$ 4,497,000
August 2025 Private Placement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Shares sold (in shares) \| shares	3,138,338
Proceeds from issuance of common stock	$ 3,500,000
Dr. Jean Bennett's [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Consulting expense									$ 0	$ 0
Consultation services receivable period									1 year
Dr. George Magrath [Member] \| March 2025 Private Placement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Agreement made with investments			$ 500,000
Cam Gallagher [Member] \| March 2025 Private Placement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Agreement made with investments			$ 1,000,000
Restricted Stock Units [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares									1,688,361	1,025,022
Restricted Stock Units [Member] \| Dr. Jean Bennett's [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares				100,000
Restricted Stock Units [Member] \| 2020 Equity Incentive Plan [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares									1,688,361	1,025,022
Dr. Pepose [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Number of equal annual installments for vesting \| Installment					12
Consulting expense									$ 500,000	$ 500,000
Consulting expenses unpaid									$ 100,000	$ 100,000
Dr. Pepose [Member] \| Restricted Stock Units [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares						32,000
Dr. Pepose [Member] \| Stock Option [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Granted (in shares) \| shares						48,000
Foundation Fighting Blindness [Member] \| 2022 Binding Letter Agreement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Amount funded to support study							$ 2,000,000
Amount funded to support study payable in initial installment							$ 400,000
Number of annual installments \| Installment							4
Amount funded to support study payable in annual installment							$ 400,000
Payment of final installment amount upon termination of agreement		$ 400,000
Payments due related to amount funded to support study		0
Foundation Fighting Blindness [Member] \| 2025 Letter Agreement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Amount funded to support study payable in initial installment		$ 300,000
Number of annual installments \| Installment		2
Period of agreement termination after study completion									2 months
Final installment payable upon receipt of semi-annual reports of study		$ 300,000
Payment of initial installment								$ 300,000
Potential payment of additional installment									$ 300,000
Cam Gallagher [Member] \| August 2025 Private Placement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Proceeds from issuance of common stock	1,000,000
Sean Ainsworth [Member] \| August 2025 Private Placement [Member]
Pre-Merger Financing and Waiver Agreements [Abstract]
Proceeds from issuance of common stock	$ 100,000